-
DE
Ubiquinol kinetics describes how the body absorbs, distributes, metabolizes, and eliminates the reduced form of Coenzyme Q10. Understanding these processes is key to assessing the bioavailability and effectiveness of ubiquinol supplements.
Ubiquinol kinetics describes how the body absorbs, distributes, metabolizes, and eliminates the reduced form of Coenzyme Q10. Understanding these processes is key to assessing the bioavailability and effectiveness of ubiquinol supplements.
Ubiquinol kinetics is a branch of pharmacology that describes the time-dependent processes occurring in the human body following the ingestion of ubiquinol. Ubiquinol is the biologically active, reduced form of Coenzyme Q10 (CoQ10) and plays a central role in cellular energy production and antioxidant defense. Its kinetics encompass four fundamental processes: absorption, distribution, metabolism, and elimination -- collectively known as ADME.
Ubiquinol is absorbed in the small intestine, where it is incorporated into micelles and transported across the intestinal mucosa. As a highly lipophilic (fat-soluble) molecule, its absorption is significantly enhanced when taken alongside fatty meals. Compared to the oxidized form (ubiquinone), ubiquinol demonstrates markedly superior bioavailability, as it does not require enzymatic conversion to become biologically active in the body.
Following absorption, ubiquinol is transported via the lymphatic system and subsequently enters systemic circulation. In the bloodstream, it is primarily bound to lipoproteins such as LDL and HDL. Distribution occurs across numerous tissues, with particularly high concentrations found in metabolically active organs such as the heart, liver, kidneys, and skeletal muscles. Ubiquinol is a natural component of all human cells and is predominantly localized within the mitochondria, the energy-producing organelles of the cell.
Within the body, a dynamic equilibrium exists between the oxidized form ubiquinone and the reduced form ubiquinol. Under physiological conditions, approximately 90 to 95 percent of total plasma CoQ10 exists in the ubiquinol form. Oral supplementation with ubiquinol results in a significant increase in plasma levels. Metabolism occurs primarily via hepatic (liver-based) pathways, though the precise metabolic routes remain an active area of research.
Ubiquinol and its metabolites are excreted predominantly via the bile and feces. Renal (urinary) excretion plays a minor role. The plasma half-life of ubiquinol ranges from approximately 33 to 49 hours depending on the study and dosage, suggesting slow turnover and good tissue accumulation.
Understanding ubiquinol kinetics is of great importance for the development of effective nutritional supplements and therapeutic applications. Key clinically relevant considerations include:
Both ubiquinol and ubiquinone are forms of Coenzyme Q10 but differ in their redox state. Ubiquinol (QH2) is the fully reduced, antioxidantly active form, while ubiquinone (Q) is the oxidized form. Studies indicate that ubiquinol supplementation results in higher plasma concentrations than equivalent doses of ubiquinone, supporting its superior bioavailability.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.